Abstract
Purpose: Resistant rejection in pediatric heart transplant patients is a cause of significant mortality; we describe the first successful use of Campath-1H in this setting. Campath-1H is an anti-CD52 monoclonal antibody, primarily utilized for treatment of GVH disease. CD52 is found on T & B cells, macrophages, monocytes and NK cells.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have